Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (441-450 of 588) with videos related to

Pageof 59
Sort By:
Diabetes, Obesity & Metabolism|November 25, 2024
Development and external validation of an algorithm for self-identification of risk for microvascular complications in patients with type 1 diabetesWei Liu, Xiaodan Hu, Yayu Fang, et al.
Diabetes, Obesity & Metabolism|September 4, 2023
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trialLinong Ji, Jinmiao Lu, Leili Gao, et al.
Diabetes, Obesity & Metabolism|March 19, 2026
A Four-Variant T1D Genetic Risk Score to Classify Type 1 and Monogenic Diabetes in Chinese PatientsWei Liu, Ruiqing Xing, Xiaoling Cai, et al.
Endocrinology, Diabetes & Metabolism|January 14, 2022
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort studySuzanne V Arnold, Kamlesh Khunti, Fengming Tang, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programmeKamlesh Khunti, Hungta Chen, Javier Cid-Ruzafa, et al.
Primary Care Diabetes|August 6, 2023
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetesPernilla Aarskog, Javier Cid-Ruzafa, Hungta Chen, et al.
Diabetes Research and Clinical Practice|July 30, 2023
Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) RegisterLee-Ling Lim, Eric S H Lau, Siew Pheng Chan, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC ModelLee-Ling Lim, Eric S H Lau, Juliana N M Lui, et al.
Diabetes Research and Clinical Practice|July 12, 2021
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER studyLinong Ji, Fabrice Bonnet, Hungta Chen, et al.
The American Journal of Medicine|July 2, 2013
Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patientsLinong Ji, Dayi Hu, Changyu Pan, et al.
Pageof 59

Showing results (441-450 of 588) with videos related to

Sort By:
Pageof 59
Diabetes, Obesity & Metabolism|November 25, 2024
Development and external validation of an algorithm for self-identification of risk for microvascular complications in patients with type 1 diabetesWei Liu, Xiaodan Hu, Yayu Fang, et al.
Diabetes, Obesity & Metabolism|September 4, 2023
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trialLinong Ji, Jinmiao Lu, Leili Gao, et al.
Diabetes, Obesity & Metabolism|March 19, 2026
A Four-Variant T1D Genetic Risk Score to Classify Type 1 and Monogenic Diabetes in Chinese PatientsWei Liu, Ruiqing Xing, Xiaoling Cai, et al.
Endocrinology, Diabetes & Metabolism|January 14, 2022
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort studySuzanne V Arnold, Kamlesh Khunti, Fengming Tang, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programmeKamlesh Khunti, Hungta Chen, Javier Cid-Ruzafa, et al.
Primary Care Diabetes|August 6, 2023
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetesPernilla Aarskog, Javier Cid-Ruzafa, Hungta Chen, et al.
Diabetes Research and Clinical Practice|July 30, 2023
Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) RegisterLee-Ling Lim, Eric S H Lau, Siew Pheng Chan, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC ModelLee-Ling Lim, Eric S H Lau, Juliana N M Lui, et al.
Diabetes Research and Clinical Practice|July 12, 2021
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER studyLinong Ji, Fabrice Bonnet, Hungta Chen, et al.
The American Journal of Medicine|July 2, 2013
Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patientsLinong Ji, Dayi Hu, Changyu Pan, et al.
Pageof 59